Compare · head to head
Rigel Pharmaceuticals vs Suncor
Suncor ranks higher overall — 360 rank 95 vs 66.
Rigel Pharmaceuticals leads on Value (68 vs 57). Suncor leads on Growth (64 vs 42). The two are close on Quality and Sentiment.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | Canada |
| Sector | Health Care | Energy & Oil |
| Industry | Biotechnology | Oil, Gas & Consumable Fuels |
| Size | Small | Large |
| ISIN | US7665597024 | CA8672241079 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 66 | 95 |
| Value | 68 | 57 |
| Quality | 66 | 70 |
| Growth | 42 | 64 |
| Safety | NR | 73 |
| Sentiment | 40 | 41 |
| Quality details | ||
| Profitability | 82 | 74 |
| Cash Truth | NR | 66 |
Rigel Pharmaceuticals vs Kura OncologyRigel Pharmaceuticals vs Myriad GeneticsRigel Pharmaceuticals vs KORU Medical SystemsAdd a third stock →
Full analyses: Rigel Pharmaceuticals · Suncor
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100